The big focus in the coming week is on central banks, with company reporting season winding down. Expectations have been growing for rate cuts next year, so.
Macto news continues to dominate the agenda in the early part of the week with US inflation the top item tomorrow. If nothing else, it should be a good.
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Separately, Piper Sandler raised their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on Thursday, November 9th. […]
Swiss National Bank boosted its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 46.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 96,300 shares of the company’s stock after buying an additional 30,700 shares during the period. Swiss National Bank’s holdings in Akero Therapeutics were worth $4,496,000 at the end […]
Octopus Apollo VCT plc Director Appointment Octopus Apollo VCT plc is delighted to announce the appointment of Gillian Elcock as an independent non-executive director of the Company with effect.